EP3205650
EGFR HEMILL, TILREIÐSLA OG NOTKUN HANS
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.9.2015EP published:
4.8.2021EP application number:
15849629.9
EP translation filed:
3.9.2021Grant published:
15.10.2021EPO information:
European Patent Register
Max expiry date:
29.9.2035Expiry date:
29.9.2026Next due date:
30.9.2026
Title:
EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF
Timeline
Today
30.9.2015EP application
4.8.2021EP Publication
3.9.2021Translation submitted
15.10.2021Registration published
29.9.2026Expires
Owner
Name:
Shanghai Hansoh Biomedical Co., Ltd.Address:
Building 2 No.3728 Jinke Road Zhangjiang Hi-Tech Park, Shanghai 201203, CN
Name:
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.Address:
The 10th Industrial Sub-zone of Development Zone Lianyungang, Jiangsu 222047, CN
Inventor
Name:
WEI, MingsongAddress:
Shanghai 201203, CN
Name:
SUN, GuangjunAddress:
Shanghai 201203, CN
Name:
TAN, SongliangAddress:
Shanghai 201203, CN
Name:
GAO, PengAddress:
Shanghai 201203, CN
Name:
WANG, ShaobaoAddress:
Shanghai 201203, CN
Name:
XIU, WenhuaAddress:
Shanghai 201203, CN
Name:
ZHANG, FujunAddress:
Shanghai 201203, CN
Name:
BAO, RudiAddress:
Shanghai 201203, CN
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201410534203Date:
11.10.2014Country:
CN
Classification
Categories:
C07D 239/48, C07D 403/04, C07D 403/12, C07D 413/14, C07D 405/12, C07D 405/14, C07D 471/06, C07D 471/10, C07D 491/10, C07D 491/107, C07F 9/53, A61K 31/506, A61K 31/505, A61K 31/675
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 7.9.2021
Expires: 29.9.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 31.8.2022
Expires: 29.9.2023
Payer: Patice ehf.
Number: 9
Paid: 28.9.2023
Expires: 29.9.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.8.2024
Expires: 29.9.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 15.9.2025
Expires: 29.9.2026
Payer: Árnason Faktor ehf.